| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sarepta Therapeutics, Inc. | Chief Financial Officer | Common Stock | 135,320 | $2,503,420 | $18.50 | 09 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics, Inc. | 09 Mar 2026 | 2 | $0 | 4 | Chief Financial Officer | 11 Mar 2026, 20:08 |
| SRPT | Sarepta Therapeutics, Inc. | 02 Mar 2026 | 1 | -$7,290 | 4 | Chief Financial Officer | 03 Mar 2026, 20:05 |
| SRPT | Sarepta Therapeutics, Inc. | 01 Dec 2025 | 2 | -$3,312 | 4 | Chief Financial Officer | 10 Dec 2025, 20:05 |
| SRPT | Sarepta Therapeutics, Inc. | 03 Sep 2025 | 2 | $0 | 4 | Chief Financial Officer | 05 Sep 2025, 21:30 |
| SRPT | Sarepta Therapeutics, Inc. | 31 Jul 2025 | 1 | -$5,369 | 4 | Chief Financial Officer | 04 Aug 2025, 20:10 |
| SRPT | Sarepta Therapeutics, Inc. | 16 Jul 2025 | 0 | $0 | 3 | Chief Financial Officer | 04 Aug 2025, 20:00 |